CAS: 4152-09-4; N1-Benzylethane-1,2-Diamine

该化合物是制药,农用化学品和其他精美化学品的生产.它的防雷功能组允许它参与各种化学反应,例如核糖类替代和凝聚反应.此外,它可以作为一根结扎和化学协调的混合物,与金属离子形成复杂体.安全考虑包括谨慎处理,因为它可能造成皮肤和眼部刺激.在一个冷却,干燥的地方储存不相容物质对于保持其稳定性和有效性至关重要.总的来说,N-苯乙二烯是化学研究和工业应用的宝贵化合物,因为其具有回旋性和功能性.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

ethyleneimine benzylamine formic acid N,N'-bis(benzyliden)ethylendiamineN-Benzyl-N,N'-dibenzoylethylenediamine N-benzyl-N',N'''-diphenyl-N,N''-ethanediyl-bis-thioureaN-benzyl-N',N'''-diphenyl-N,N''-ethanediyl-bis-thiourea 1-benzyl-2-methyl-4,5-dihydro-1H-imidazole (3-benzyl-2-diethylamino-[1,3,2]diazaphospholidin-1-yl)-phosphonous acid bis-diethylamide

合成工艺路线路线简述

    溴甲苯置于potassium Carbonate,三氟乙酸体系中,用 二氯甲烷,乙腈 作为反应溶剂,化学反应 3.0H,反应生成 N-苄基乙二胺
    参考文献:新型咪唑并[1,2-A]吡啶-3-羧酰胺衍生物的设计,合成及抗分枝杆菌活性
    标题:新型咪唑并[1,2-A]吡啶-3-羧酰胺衍生物的设计,合成及抗分枝杆菌活性
    摘要:我们在此报告基于我们实验室中发现的imb-1402的结构和合成的"新型咪唑并[1,2-A]吡啶-3-甲酰胺(ipa)"的设计和合成.结果表明,在苯环上具有给电子基团的2,6-二甲基-N-[2-(苯基氨基)乙基] Ipas作为有效的支架.化合物26G和26H对药物敏感/耐药的mtb菌株具有相当大的活性(mic:0.041-2.64μm),并且它们对mtb H37Rv的安全性指标可接受,Si值分别为4395和1405.此外,N-[2-(哌嗪-1-基)乙基]部分也被鉴定为潜在的替代接头(化合物31),为进一步的sar研究开辟了新的方向.
    DOI:10.1016/j.Ejmech.2017.05.044

    海关参考信息

    专利信息


    专利号:WO-0058264-A1
    优先权日:1999-03-26
    标 题:Method for the synthesis of non-symmetrical dtpa compounds
    发明人:ACHILEFU SAMUEL I; SRINIVASAN ANANTHACHARI
    权利人:MALLINCKRODT INC; ACHILEFU SAMUEL I; SRINIVASAN ANANTHACHARI
    摘要:The synthesis of compounds of formula (XIV) wherein each R4 is an alkyl group having 1 to 15 carbon atoms, and R6 is a linking moiety having 1 to 10 carbon atoms, is disclosed. These compounds are useful intermediates in the synthesis of compounds of formula (X). These compounds are useful in the preparation of nuclear pharmaceuticals such as those used for tumor imaging or tumor therapy.

    专利号:WO-0058266-A1
    优先权日:1999-03-26
    标题:Divergent method for the synthesis of diethylene triaminepenta aceticacid esters
    发明人:ACHILEFU SAMUEL I; SRINIVASAN ANANTHACHARI
    权利人:MALLINCKRODT INC; ACHILEFU SAMUEL I; SRINIVASAN ANANTHACHARI
    摘要:The synthesis of compounds of formula (X) is disclosed. These compounds are useful in the preparation of nuclear pharmaceuticals such as those used for tumor imaging or tumor therapy.

    专利号:US-2008287407-A1
    优先权日:2003-12-10
    标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
    发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
    权利人:NITROMED INC
    摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

    专利号:US-2016168138-A1
    优先权日:2013-07-15
    标题:Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant
    发明人:IQBAL JAVED; DAHANUKAR VILAS HARESHWAR; ORUGANTI SRINIVAS; KANDAGATLA BHASKAR
    权利人:REDDY S LAB LIMTED DR
    摘要:A novel processes for the preparation of suvorexant (formula I), its related compounds and its intermediates that are simple, economical and commercially viable. (I)

    专利号:US-2009111737-A1
    优先权日:1999-05-24
    标题:Novel antibacterial agents
    发明人:CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
    权利人:CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
    摘要:This invention relates to novel multibinding compounds (agents) that are antibacterial agents. The multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands in their monovalent (i.e., unlinked) state have the ability to bind to a an enzyme involved in cell wall biosynthesis and metabolism, a precursor used in the synthesis of the bacterial cell wall and/or the bacterial cell surface thereby interfere with the synthesis and/or metabolism of the cell wall. In particular the multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands hasn a ligand domain capable of binding to penicillin binding proteins, a transpeptidase enzyme, a substrate of a transpeptidase enzyme, a beta-lactamase enzyme, pencillinase enzyme, cephalosporinase enzyme, a transglycoslase enzyme, or a transglycosylase enzyme substrate; Preferably, the ligands are selected from the beta lactam or glycopeptide class of antibacterial agents.

    专利号:US-2013102730-A1
    优先权日:2010-04-02
    标 题:Polyamine-containing polymers and methods of synthesis and use
    发明人:JOST ROBERT W; ULUDAG HASAN; BOLUK MEHMET YAMAN
    权利人:JOST ROBERT W; ULUDAG HASAN; BOLUK MEHMET YAMAN; ALBERTA INNOVATES TECHNOLOGY FUTURES
    摘要:The present invention relates to polyamine-containing polymers and methods of their synthesis and use. The polymer may be hydroxyethylcellulose, dextran, poly(vinyl alcohol) or poly(methyl acrylate).
    山东西亚化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xiyashiji.com
    企业联系电话:400-990-3999👤
    📞山东西亚化学有限公司 ⚠️参考联系方式
    联系人:徐雪
    电话:400-990-3999
    手机:13395398332
    传真:0539-6365991
    邮箱:3007715518@qq.com
    通信地址: 临沭经济开发区化工园区(厂址)
    邮编: 276000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:临沭经济开发区化工园区(厂址)
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Ye, Z.-S., Science of Synthesis Knowledge Updates, (2021) 2, 363.
    摘要:Ye, Z.-S., Science of Synthesis Knowledge Updates, (2021) 2, 359.
    摘要:Ye, Z.-S., Science of Synthesis Knowledge Updates, (2021) 2, 364.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知